Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. FI: 55.87

Farnier M Robinson JG, ODYSSEY LONG TERM Investigators, Maria Assumpta Caixas Pedragos

Research output: Contribution to journalArticleResearch

1359 Citations (Scopus)
Original languageEnglish
Pages (from-to)1489-1499
JournalThe New England Journal of Medicine
Volume372
Issue number16
Publication statusPublished - 1 Jan 2015

Cite this